Green Bay community gathers to honor Tyler Kreiter, a dedicated firefighter lost to cancer
Lt. Tyler Kreiter, a 43-year-old engineer/paramedic and 17-year Green Bay Metro Fire Department veteran, died last week after ...
Philly biotech Adaptimmune gives first dose of first-of-its-kind therapy
A local biotech company with a new approach to cancer recently administered the first commercial dose of its signature ...
Cure Today29 天
T-Cell Therapy With Lete-Cel Demonstrates Efficacy in Sarcoma Subtypes
Letetresgene autoleucel (lete-cel) showed a 42% response rate in a phase 2 trial for synovial sarcoma and myxoid/round cell liposarcoma. The trial included 64 patients, with 41% response in synovial ...
Yahoo Finance1 个月
Adaptimmune nears second sarcoma approval as Phase II trial hits endpoints
In synovial sarcoma, the median response lasted for 18.3 months, while in MRCLS, the median response was 12.2 months. All patients experienced treatment-emergent adverse events (TEAEs), including ...